What makes the“Hold-and-Kill”strategy a promising approach in targeted cancer therapy? Join ICE Bioscience at the 9th Annual TPD & Induced Proximity Summit in Boston to explore how RIPTAC technology connects target engagement with selective cancer cell killing.
At the meeting, ICE Bioscience will present a poster entitled: "Hold-and-Kill: Decoding RIPTAC Mechanism of Action and Novel Target Pair Validation Strategies”
Join us at Booth #13 and dive into our featured poster. Let's discuss RIPTAC research, target pair validation, and how integrated mechanistic studies can support the development of next-generation induced-proximity therapeutics.
Location: Boston, MA
Date: October 26–29, 2026
Booth: #13
PREV：Join us at RSC-BMCS/SCI Targeted Protein...
NEXT：There's no more
2026-10-16
2026-10-16
2026-09-24
2026-09-23
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
Get a quote
Go top
